Latest Stock Buy or Sell? Make More Informed Decisions!

Today, John Hood commented about whether ITA-BATS, CT3, CTCADY3, ZWC-T, BSC-T, ZRR-T, FIE-T, HHL-T, VSP-T, VSP-T, VCN-T, TXF-T, ZWE-T, VOO-N, KRBN-N, ZEB-T, ZUH-T are stocks to buy or sell.

COMMENT
Doesn't believe economy has entered into recession. Emotional fear of recession major concern, not the actual fundamentals of the market. If US Fed raises rates too high & too fast - could tip economy into recession.
COMMENT
Believes equity markets have not priced a recession into markets. Would buy into the market if S&P 500 goes to ~3800 mark. S&P 500 @ 3300 would be great buying opportunity. Is looking into buying healthcare (aging baby boomers) and banking stocks.
BUY
Well diversified health care ETF (hospitals, surgical implements etc.) Matter of when to buy is the question.
BUY
Optimistic about future of Canadian banks. Recent market sell off doesn't affect underlying business. Strong banking system in Canada.
N/A
Very niche ETF based on commodity prices which makes hard to value. Product made for investors interested in climate change and carbon capture. Investor concerns for ESG seems to be going down (could be a reversal of trends).
BUY
Standard for industry trying to mimic the S&P 500. Very well preforming ETF that is good investment for average investor. Low costs ETF make product very attractive. Attraction of business model is obsession of lowering costs for investors.
DON'T BUY
Problem with European business is government politics get in the way. Quality business names but difficult to make high returns in Europe. Would prefer US or Canadian banking ETFs.
DON'T BUY
Very strong yield on product, but involves risk of investing in tech. Better places to earn consistent yield.
PAST TOP PICK
(A Top Pick Feb 22/22, Down 7%) Market beating returns given poor overall market returns. Would keep as has mirrored performance of S & P composite index.
COMMENT
Has out performed market given overall selloff. Will continue to hold.
PAST TOP PICK
(A Top Pick Feb 22/22, Down 4%) Market beating returns given overall market selloff. Unique combination of bond and preferred share structure. Will continue to look into buying more shares.
BUY
Interesting company due to strong yield. Main issue is not as strong of growth as other stocks. Return has been strong regardless. Good for investors looking for income, but not growth.
DON'T BUY
Strong dividend payouts has led to shares being traded for long time. Not a strong return on capital. Would not recommend buying.
DON'T BUY
Would not recommend buying. Doesn't like real return bonds. Doesn't use this style of bond.
DON'T BUY
Does not like product's use of leverage or alternative method's to generate yield. Suspicious of yield being higher than underlying assets. Would not recommend buying.